Modeling frameworks for radiation induced lymphopenia: A critical review.
Saved in:
| Title: | Modeling frameworks for radiation induced lymphopenia: A critical review. |
|---|---|
| Authors: | Cella, Laura1 (AUTHOR) laura.cella@cnr.it, Monti, Serena1 (AUTHOR), Pacelli, Roberto2 (AUTHOR), Palma, Giuseppe3 (AUTHOR) |
| Source: | Radiotherapy & Oncology. Jan2024, Vol. 190, pN.PAG-N.PAG. 1p. |
| Subjects: | Lymphopenia, Radiotherapy, Overall survival, Cancer treatment, Radiation |
| Abstract: | • Radiation-induced lymphopenia (RIL) is a frequent and important side effect of radiation therapy. • The detrimental effect of RIL on cancer therapeutic outcomes has been demonstrated. • Different frameworks for modelling RIL has been reported in the literature. • Harmonization among the diverse RIL modelling approaches is needed. Radiation-induced lymphopenia (RIL) is a frequent, and often considered unavoidable, side effect of radiation therapy (RT), whether or not chemotherapy is included. However, in the last few years several studies have demonstrated the detrimental effect of RIL on therapeutic outcomes, with conflicting findings concerning possible inferior patient survival. In addition, since immunotherapeutic treatment has become an integral part of cancer therapy, preserving the immune system is recognized as crucial. Given this background, various research groups have reported on different frameworks for modelling RIL, frequently based on different definitions of RIL itself, and discordant results have been reported. Our aim is to critically review the current literature on RIL modelling and summarize the different approaches recently proposed to improve the prediction of RIL after RT and aimed at immunity-sparing RT. A detailed description of these approaches will be outlined and illustrated through their applications as found in the literature from the last five years. Such a critical analysis represents the necessary starting step to develop an effective strategy that ultimately could harmonize the diverse modelling methods. [ABSTRACT FROM AUTHOR] |
| Copyright of Radiotherapy & Oncology is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Engineering Source |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: egs DbLabel: Engineering Source An: 175498632 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Modeling frameworks for radiation induced lymphopenia: A critical review. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Cella%2C+Laura%22">Cella, Laura</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> laura.cella@cnr.it</i><br /><searchLink fieldCode="AR" term="%22Monti%2C+Serena%22">Monti, Serena</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pacelli%2C+Roberto%22">Pacelli, Roberto</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Palma%2C+Giuseppe%22">Palma, Giuseppe</searchLink><relatesTo>3</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Radiotherapy+%26+Oncology%22">Radiotherapy & Oncology</searchLink>. Jan2024, Vol. 190, pN.PAG-N.PAG. 1p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Lymphopenia%22">Lymphopenia</searchLink><br /><searchLink fieldCode="DE" term="%22Radiotherapy%22">Radiotherapy</searchLink><br /><searchLink fieldCode="DE" term="%22Overall+survival%22">Overall survival</searchLink><br /><searchLink fieldCode="DE" term="%22Cancer+treatment%22">Cancer treatment</searchLink><br /><searchLink fieldCode="DE" term="%22Radiation%22">Radiation</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: • Radiation-induced lymphopenia (RIL) is a frequent and important side effect of radiation therapy. • The detrimental effect of RIL on cancer therapeutic outcomes has been demonstrated. • Different frameworks for modelling RIL has been reported in the literature. • Harmonization among the diverse RIL modelling approaches is needed. Radiation-induced lymphopenia (RIL) is a frequent, and often considered unavoidable, side effect of radiation therapy (RT), whether or not chemotherapy is included. However, in the last few years several studies have demonstrated the detrimental effect of RIL on therapeutic outcomes, with conflicting findings concerning possible inferior patient survival. In addition, since immunotherapeutic treatment has become an integral part of cancer therapy, preserving the immune system is recognized as crucial. Given this background, various research groups have reported on different frameworks for modelling RIL, frequently based on different definitions of RIL itself, and discordant results have been reported. Our aim is to critically review the current literature on RIL modelling and summarize the different approaches recently proposed to improve the prediction of RIL after RT and aimed at immunity-sparing RT. A detailed description of these approaches will be outlined and illustrated through their applications as found in the literature from the last five years. Such a critical analysis represents the necessary starting step to develop an effective strategy that ultimately could harmonize the diverse modelling methods. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of Radiotherapy & Oncology is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=egs&AN=175498632 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.radonc.2023.110041 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: N.PAG Subjects: – SubjectFull: Lymphopenia Type: general – SubjectFull: Radiotherapy Type: general – SubjectFull: Overall survival Type: general – SubjectFull: Cancer treatment Type: general – SubjectFull: Radiation Type: general Titles: – TitleFull: Modeling frameworks for radiation induced lymphopenia: A critical review. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Cella, Laura – PersonEntity: Name: NameFull: Monti, Serena – PersonEntity: Name: NameFull: Pacelli, Roberto – PersonEntity: Name: NameFull: Palma, Giuseppe IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: Jan2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 01678140 Numbering: – Type: volume Value: 190 Titles: – TitleFull: Radiotherapy & Oncology Type: main |
| ResultId | 1 |